SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001575872-24-000114
Filing Date
2024-02-02
Accepted
2024-02-01 17:37:10
Documents
23
Period of Report
2024-01-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K sxtp-20240129.htm   iXBRL 8-K 122375
2 EXHIBIT 1.1 cm474_ex1-1.htm EX-1.1 445417
3 EXHIBIT 4.1 cm474_ex4-1.htm EX-4.1 301513
4 EXHIBIT 4.2 cm474_ex4-2.htm EX-4.2 201302
5 EXHIBIT 4.3 cm474_ex4-3.htm EX-4.3 263377
6 EXHIBIT 4.4 cm474_ex4-4.htm EX-4.4 199279
7 EXHIBIT 99.1 cm474_ex99-1.htm EX-99.1 22983
8 EXHIBIT 99.2 cm474_ex99-2.htm EX-99.2 24055
  Complete submission text file 0001575872-24-000114.txt   1945866

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE sxtp-20240129.xsd EX-101.SCH 5098
10 XBRL CALCULATION FILE sxtp-20240129_cal.xml EX-101.CAL 667
11 XBRL DEFINITION FILE sxtp-20240129_def.xml EX-101.DEF 13050
12 XBRL LABEL FILE sxtp-20240129_lab.xml EX-101.LAB 17945
13 XBRL PRESENTATION FILE sxtp-20240129_pre.xml EX-101.PRE 13536
25 EXTRACTED XBRL INSTANCE DOCUMENT sxtp-20240129_htm.xml XML 5620
Mailing Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036
Business Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 202-327-5422
60 DEGREES PHARMACEUTICALS, INC. (Filer) CIK: 0001946563 (see all company filings)

IRS No.: 452406880 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41719 | Film No.: 24588069
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)